Observe Medical Asa
Observe Medical ASA develops and commercialize medical technology products for patients, healthcare professionals, and hospitals in Norway, Sweden, the United States, and rest of European countries. It offers Sippi, a digital and automated urine measurement system for urine monitoring and biofilm control; and Biim, a wireless pocketable ultrasound device for display of the ultrasound image and vi… Read more
Observe Medical Asa (OBSRV) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of December 2024: -1.273x
Based on the latest financial reports, Observe Medical Asa (OBSRV) has a cash flow conversion efficiency ratio of -1.273x as of December 2024.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Nkr-30.68 Million) by net assets (Nkr24.11 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Observe Medical Asa - Cash Flow Conversion Efficiency Trend (2016–2024)
This chart illustrates how Observe Medical Asa's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Observe Medical Asa Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Observe Medical Asa ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Kia Lim Bhd
KLSE:6211
|
0.014x |
|
Wi2Wi Corporation
V:YTY
|
-0.128x |
|
WeCapital Holdings, Inc.
PINK:WCHD
|
N/A |
|
DO & CO (DOQ.SG)
STU:DOQ
|
0.036x |
|
Adial Pharmaceuticals Inc
NASDAQ:ADIL
|
-0.407x |
|
Filament Health Corp
OTCQB:FLHLF
|
-0.257x |
|
TAKE-TWO INTERACT (TKE.SG)
STU:TKE
|
-0.022x |
|
Fund.com Inc
PINK:FNDM
|
0.049x |
Annual Cash Flow Conversion Efficiency for Observe Medical Asa (2016–2024)
The table below shows the annual cash flow conversion efficiency of Observe Medical Asa from 2016 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | Nkr24.11 Million | Nkr-30.68 Million | -1.273x | -483.24% |
| 2023-12-31 | Nkr112.08 Million | Nkr-24.45 Million | -0.218x | +41.25% |
| 2022-12-31 | Nkr138.31 Million | Nkr-51.37 Million | -0.371x | -123.71% |
| 2021-12-31 | Nkr-14.12 Million | Nkr-22.13 Million | 1.567x | +247.31% |
| 2020-12-31 | Nkr20.35 Million | Nkr-21.64 Million | -1.064x | -10.69% |
| 2019-12-31 | Nkr14.54 Million | Nkr-13.97 Million | -0.961x | -93.26% |
| 2018-12-31 | Nkr16.82 Million | Nkr-8.36 Million | -0.497x | +42.36% |
| 2017-12-31 | Nkr11.39 Million | Nkr-9.83 Million | -0.863x | -21.31% |
| 2016-12-31 | Nkr14.70 Million | Nkr-10.45 Million | -0.711x | -- |